PERIPROSTHETIC METALLOSIS

PERIPROSTHETIC METALLOSIS was reported 16 times

PERIPROSTHETIC METALLOSIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 RITUXIMAB-ABBS 3 0.0006
1 RISDIPLAM 1 0.0002
2 CABERGOLINE 1 0.0002
3 ANASTROZOLE TABLETS 4 0.0002
4 FLUOCINONIDE TOPICAL SOLUTION USP, 0.05% 1 0.0002
5 RIBOCICLIB 4 0.0001
6 TESTOSTERONE CYPIONATE 1 0.0001
7 ANASTROZOLE 4 0.0001
8 LETROZOLE TABLETS 4 0.0001
9 LETROZOLE 4 0.0001
10 LIFITEGRAST 1 0.0001
11 LEUPROLIDE ACETATE 4 0.0001
12 DENOSUMAB 6 0.0000
13 MIRABEGRON 1 0.0000
14 IBUPROFEN SODIUM 1 0.0000
15 LORATADINE TABLET 1 0.0000
16 CONJUGATED ESTROGENS 1 0.0000
17 ESTROGENS, CONJUGATED 1 0.0000
18 CALCIUM CARBONATE 1 0.0000
19 FENTANYL 1 0.0000
20 LORATADINE 1 0.0000
21 NAPROXEN SODIUM 1 0.0000
22 DICLOFENAC SODIUM 1 0.0000
23 ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE 1 0.0000
24 METHOTREXATE SODIUM 3 0.0000
25 LOSARTAN 1 0.0000
26 RITUXIMAB 1 0.0000
27 IBUPROFEN 1 0.0000
28 DEXAMETHASONE 1.5 MG 1 0.0000
29 DEXAMETHASONE 1 0.0000
30 METFORMIN ER 500 MG 1 0.0000
31 OMEPRAZOLE MAGNESIUM 1 0.0000
32 ACETAMINOPHEN 1 0.0000